Company Filing History:
Years Active: 2017
Title: Anke Ziegenbalg: Innovator in Tuberculosis Diagnosis
Introduction
Anke Ziegenbalg is a prominent inventor based in Stony Brook, NY (US). She has made significant contributions to the field of medical diagnostics, particularly in the detection of active tuberculosis. Her innovative work has the potential to improve the diagnosis and treatment of this serious disease.
Latest Patents
Anke Ziegenbalg holds a patent for a serologic test designed for the rapid diagnosis of active tuberculosis. This invention relates to methods and kits that utilize serological techniques to detect active tuberculosis infection in a subject. The test employs a first agent capable of binding to IgG, IgA, and/or IgM directed to a specific protein present in or on a membrane vesicle or a Calmette-Guerin (BCG) membrane vesicle. Additionally, the patent includes methods for treating a subject diagnosed with active tuberculosis disease.
Career Highlights
Anke Ziegenbalg is affiliated with the Albert Einstein College of Medicine, where she continues her research and development in medical diagnostics. Her work is crucial in addressing public health challenges associated with tuberculosis.
Collaborations
Anke has collaborated with notable colleagues, including Jacqueline Michele Achkar and Arturo Casadevall, who share her commitment to advancing medical science and improving patient outcomes.
Conclusion
Anke Ziegenbalg's contributions to tuberculosis diagnosis exemplify the impact of innovative research in healthcare. Her patent and ongoing work at the Albert Einstein College of Medicine highlight her dedication to improving diagnostic methods and treatment options for infectious diseases.